BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3848418)

  • 1. Hepatitis B surface antigen testing.
    Moraleda MH
    Infect Control; 1985 Jun; 6(6):216-7. PubMed ID: 3848418
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccination.
    Fagan EA; Williams R
    Br J Clin Pract; 1987 Jan; 41(1):569-76. PubMed ID: 2959306
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
    Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A
    J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of a collaborative study for assessing the potency of hepatitis B vaccines.
    Ferguson M; Heath A; Minor PD
    Biologicals; 1990 Oct; 18(4):345-50. PubMed ID: 2285506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.
    Stephenne J
    Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of 10(15) chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Niessen J; Brotman B; Prince AM
    J Med Virol; 1987 Nov; 23(3):289-95. PubMed ID: 2963091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to hepatitis B surface antigen (anti-HBs) induced by a recombinant hepatitis B vaccine consisting of subtype adr antigen is underestimated on the World Health Organization (WHO)-standardized assay.
    Ogata N; Takashima S; Shimaki K; Kitajima I; Watanabe A
    Intern Med; 2003 May; 42(5):446-7. PubMed ID: 12793719
    [No Abstract]   [Full Text] [Related]  

  • 8. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [20 years after the discovery of the Australia antigen].
    Grob PJ
    Schweiz Rundsch Med Prax; 1987 Dec; 76(50):1402-6. PubMed ID: 2962263
    [No Abstract]   [Full Text] [Related]  

  • 10. [The vaccine for hepatitis B virus. Definition of criteria for its use].
    Sturm JA
    Rev Paul Med; 1985; 103(1):23-31. PubMed ID: 2994199
    [No Abstract]   [Full Text] [Related]  

  • 11. Concepts of idiotype-based vaccines for hepatitis B virus and human immunodeficiency virus.
    Kennedy RC; Attanasio R
    Can J Microbiol; 1990 Nov; 36(11):811-6. PubMed ID: 2149082
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral hepatitis: 2. Hepatitis B vaccines.
    Samaranayake LP
    Dent Update; 1986 Oct; 13(9):411-4, 416. PubMed ID: 2948850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis B virus. Application of recombinant DNA technics to the development of hepatitis B vaccines and its diagnosis].
    Hamada F
    Rinsho Byori; 1988 May; 36(5):548-52. PubMed ID: 2971829
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B vaccines: blueprints for vaccines of the future.
    Kniskern PJ; Miller WJ
    Biotechnology; 1992; 20():177-204. PubMed ID: 1600381
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody to the hepatitis B virus receptor for polymerized albumin in acute infection and in hepatitis B vaccine recipients.
    Pontisso P; Schiavon E; Fraiese A; Pornaro E; Realdi G; Alberti A
    J Hepatol; 1986; 3(3):393-8. PubMed ID: 3031152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to hepatitis B vaccination.
    Waldron HA
    Br J Ind Med; 1990 May; 47(5):354-5. PubMed ID: 2141533
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.
    Emini EA; Larson V; Eichberg J; Conard P; Garsky VM; Lee DR; Ellis RW; Miller WJ; Anderson CA; Gerety RJ
    J Med Virol; 1989 May; 28(1):7-12. PubMed ID: 2723618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD4+CD25+FoxP3+ regulatory T cells in the blood of nonresponders after standard hepatitis B surface antigen vaccine immunization.
    Yang Z; Wang L; Niu W; Wu Y; Zhang J; Meng G
    Clin Immunol; 2008 May; 127(2):265-6. PubMed ID: 18304878
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.